Challenges for Clinical Drug Development in Pulmonary Fibrosis

White, Eric S.; Thomas, Matthew; Stowasser, Susanne; Tetzlaff, Kay

dc.contributor.author	Tetzlaff, Kay
dc.date.accessioned	2023-11-14T10:53:46Z
dc.date.available	2023-11-14T10:53:46Z
dc.date.issued	2022
dc.identifier.issn	1663-9812
dc.identifier.uri	http://hdl.handle.net/10900/147745
dc.language.iso	en	de_DE
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fphar.2022.823085	de_DE
dc.subject.ddc	610	de_DE
dc.title	Challenges for Clinical Drug Development in Pulmonary Fibrosis	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_02291
utue.personen.roh	White, Eric S.
utue.personen.roh	Thomas, Matthew
utue.personen.roh	Stowasser, Susanne
utue.personen.roh	Tetzlaff, Kay
dcterms.isPartOf.ZSTitelID	Frontiers in Pharmacology	de_DE
dcterms.isPartOf.ZS-Issue	Article 823085	de_DE
dcterms.isPartOf.ZS-Volume	13	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE